4min chapter

New Books in Finance cover image

Victor Roy, "Capitalizing a Cure: How Finance Controls the Price and Value of Medicines" (U California Press, 2023)

New Books in Finance

CHAPTER

Why Did Gilead's Pricing Approach Cause an Outcry?

Gilead's pricing approach triggered a crisis in treatment access and a contentious public debate over the value of new breakthroughs. Cephaspavir is a treatment for infectious disease, hepatitis C. The price that Gilead said at the time was, you know, north in the US of $90,000 for a three month treatment.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode